Valuation: Prince Pharmaceutical Co., Ltd.

Market Cap 1.11B 34.31M 29.99M 27.73M 25.45M 48.16M 3.31B 49M 331M 130M 1.61B 129M 126M 5.57B P/E 2024
-15x
P/E 2025 11.9x
Enterprise Value 1.38B 42.65M 37.28M 34.48M 31.64M 59.88M 4.11B 60.92M 411M 162M 2.01B 160M 157M 6.93B EV / Sales 2024
1.68x
EV / Sales 2025 1.33x
Free-Float
42.7%
Yield 2024 *
-
Yield 2025 1.61%
1 day-0.17%
Current month+1.51%
1 month+2.02%
3 months-0.82%
6 months-2.58%
Current year-2.73%
1 week 28.85
Extreme 28.85
31.7
1 month 27.55
Extreme 27.55
32.5
Current year 26.5
Extreme 26.5
32.5
1 year 24.25
Extreme 24.25
35.85
3 years 18.5
Extreme 18.5
41.55
5 years 18.5
Extreme 18.5
75.2
10 years 18.5
Extreme 18.5
75.2
Manager TitleAgeSince
Chief Executive Officer - 2021-12-09
Director of Finance/CFO - 2008-06-01
Chief Tech/Sci/R&D Officer - 1991-01-31
Director TitleAgeSince
Chairman - -
Director/Board Member - 2023-01-17
Director/Board Member - 2023-01-17
Change 5-day change 1-year change 3-year change Capi.($)
-0.17%0.00%+15.24%-22.44% 34.44M
-0.93%-0.62%+33.63%+80.58% 13.15B
-4.83%+18.08%-26.40%+248.83% 8.64B
-0.30%+8.04%-13.64%-51.98% 2.47B
-3.49%+9.28% - - 1.61B
-0.83%-9.03%-78.75%-67.02% 1.41B
+1.60%+10.75%-21.99%-19.06% 1.35B
-0.80%-1.59%+33.30%-6.64% 1.29B
-0.10%+2.62%+20.55%+45.60% 1.24B
+1.60%-6.00%-63.49%-67.19% 1.05B
Average -0.82%+1.75%-11.29%+15.63% 3.22B
Weighted average by Cap. -1.82%+1.87%+1.38%+95.90%

Financials

2024 2025
Net sales 690M 21.38M 18.69M 17.28M 15.86M 30.01M 2.06B 30.53M 206M 80.96M 1.01B 80.28M 78.52M 3.47B 1.06B 32.72M 28.6M 26.45M 24.27M 45.94M 3.15B 46.74M 315M 124M 1.54B 123M 120M 5.32B
Net income -53.54M -1.66M -1.45M -1.34M -1.23M -2.33M -160M -2.37M -15.99M -6.28M -78.06M -6.23M -6.09M -269M 96.32M 2.98M 2.61M 2.41M 2.21M 4.19M 288M 4.26M 28.77M 11.3M 140M 11.21M 10.96M 485M
Net Debt 358M 11.09M 9.69M 8.97M 8.23M 15.57M 1.07B 15.84M 107M 42M 522M 41.65M 40.74M 1.8B 269M 8.35M 7.3M 6.75M 6.19M 11.72M 804M 11.92M 80.47M 31.61M 393M 31.35M 30.66M 1.36B
Logo Prince Pharmaceutical Co., Ltd.
Prince Pharmaceutical Co Ltd is a Taiwan-based Company engaged in the manufacture and sale of health food and ingredients. The Company's main business is divided into ingredients business and health food business. The ingredients business currently consists of phlegm dispelling agents, vitamin B1 derivatives, and non-steroidal anti-inflammatory drugs. The health food business is mainly engaged in the original equipment manufacturer (OEM) and original design manufacturer (ODM) of health food products, providing a series of integrated services from product formulation design, research and development to the production and packaging of various dosage forms. The Company sells its products mainly in domestic and overseas markets, including Japan and Korea.
Employees
216
Date Price Change Volume
26-07-16 NT$30.25 -0.17% 110
26-07-15 NT$30.30 +0.17% 6,032
26-07-14 NT$30.25 0.00% 231
26-07-13 NT$30.25 -0.17% 10,411
26-07-09 NT$30.30 +0.17% 2,940
  1. Stock Market
  2. Stocks
  3. 6935 Stock